(Letrozole)
Letrozole Bluefish contains the active substance letrozole. Letrozole belongs to a group of medicines called aromatase inhibitors. It is used in the hormonal treatment of breast cancer. The growth of breast cancer is often stimulated by estrogens, which are female sex hormones. Letrozole reduces the amount of estrogen by inhibiting the activity of the enzyme (aromatase) that affects estrogen production, and thus can slow down the growth of malignant breast tumors that need estrogens to grow. As a result of this action, cancer cells stop growing or grow slowly and (or) stop spreading to other parts of the body.
Letrozole Bluefish is used to treat breast cancer in postmenopausal women, i.e., women who have stopped menstruating.
This medicine is used to prevent breast cancer recurrence. It can be used as the first treatment before breast cancer surgery, when immediate surgery is not recommended, or it can be used as the first treatment in patients after breast cancer surgery or after 5 years of tamoxifen treatment. Letrozole Bluefish is also used to prevent the spread of breast cancer in women with advanced breast cancer.
In case of doubts about the action of Letrozole Bluefish and why it was prescribed to the patient, the patient should ask their doctor.
Always follow the doctor's instructions carefully. They may differ from the general information contained in this package leaflet.
If any of the above conditions apply to the patient, do not take this medicine and tell your doctor.
If any of the above conditions apply to the patient, tell your doctor. The doctor will take this information into account during treatment with Letrozole Bluefish.
Letrozole may cause tendon inflammation or damage (see section 4). If the patient experiences pain or swelling of the tendons, they should rest the affected area and contact their doctor.
This medicine should not be used in children and adolescents.
Letrozole Bluefish can be used in patients aged 65 and older at the same doses as in other adult patients.
Tell your doctor or pharmacist about all medicines currently being taken or recently taken, as well as any medicines planned to be taken, including those available without a prescription.
If dizziness, fatigue, drowsiness, or general malaise occur, do not drive or operate any tools or machines until normal well-being returns.
Letrozole Bluefish contains lactose (milk sugar). If the patient has been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
This medicine should always be taken according to the doctor's instructions. In case of doubts, consult a doctor or pharmacist.
The usual dose of Letrozole Bluefish is one tablet once a day. Taking Letrozole Bluefish every day at the same time makes it easier to remember when to take the next dose.
The tablet can be taken with or without food and should be swallowed whole, washed down with a glass of water or another drink.
Letrozole Bluefish should be taken every day, as long as the doctor recommends. It may be necessary to take the medicine for several months or even several years. In case of any questions about how long to take Letrozole Bluefish, consult a doctor.
This medicine should always be taken under close medical supervision. The doctor will regularly check the patient's health to ensure that the treatment is effective.
Letrozole Bluefish may cause thinning or loss of bone tissue (osteoporosis) related to the decrease in estrogen levels in the body. The doctor may order a bone density test (osteoporosis screening) before, during, and after treatment.
In case of taking too many Letrozole Bluefish tablets or if someone else has taken them by mistake, contact a doctor or go to the hospital immediately.
Show the packaging of the tablets. Appropriate treatment may be necessary.
Do not stop taking Letrozole Bluefish unless the doctor advises it. See also the "Duration of treatment" section above.
Like all medicines, Letrozole Bluefish can cause side effects, although not everybody gets them.
Most side effects are mild to moderate and usually disappear within a few days or weeks of treatment.
Some side effects, such as hot flashes, hair loss, or vaginal bleeding, may be caused by the lack of estrogen in the body.
Do not be concerned by the following list of possible side effects. You may not get any of them.
Rare or uncommonside effects (i.e., may affect 1 to 100 out of 10,000 patients)
Also, tell your doctor immediately if any of the following symptoms occur while taking Letrozole Bluefish:
Some side effects are very common.They may affect more than 10 out of 100 patients.
If any of the above side effects are severe, tell your doctor.
Some side effects are common.They may affect 1 to 10 out of 100 patients.
If any of the above side effects are severe, tell your doctor.
Some side effects are uncommon.They may affect 1 to 10 out of 1,000 patients.
If any of the above side effects are severe, tell your doctor.
If any side effects occur, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: + 48 22 49 21 309, e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The active substance of the medicine is letrozole. Each film-coated tablet contains 2.5 mg of letrozole.
The other ingredients of the medicine are: lactose monohydrate, cornstarch, microcrystalline cellulose, sodium carboxymethylcellulose (type A), colloidal silicon dioxide, anhydrous, magnesium stearate.
The ingredients of the Opadry 02B38014 coating are: macrogol 4000, hypromellose 5 cP, talc, titanium dioxide (E 171), yellow iron oxide (E 172), red iron oxide (E 172).
Letrozole Bluefish is a yellow, round, biconvex film-coated tablet, 6.1 mm (± 0.2 mm) in diameter.
The medicine is available in blisters, in packs containing 30 or 100 tablets.
Bluefish Pharmaceuticals AB, P.O. Box 49013, 100 28 Stockholm, Sweden
Bluefish Pharmaceuticals AB, Gävlegatan 22, 113 30 Stockholm, Sweden.
Genepharm S.A., 18 km Marathonos Avenue, 153 51 Pallini Attikis, Greece
Member State | Medicinal product name |
Austria | Letrozol Bluefish 2,5 mg filmtabletten |
Germany | Letrozol Bluefish 2,5 mg filmtabletten |
Denmark | Letrozol Bluefish 2,5 mg |
Spain | Letrozole Bluefish 2,5 mg comprimidos recubiertos con película |
Finland | Letrozole Bluefish 2,5 mg tabletti, kalvopäällysteinen Letrozole Bluefish 2,5 mg filmdragerade tabletter |
France | Letrozole Bluefish 2,5 mg comprimés peliculés |
Ireland | Letrozole Bluefish 2,5 mg film-coated tablets |
Italy | Brestoral 2,5 mg compresse rivestite con film |
Poland | Letrozole Bluefish |
Sweden | Letrozole Bluefish 2,5 mg filmdragerade tabletter |
Date of last revision of the package leaflet:2019-09-26
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.